BEST TRADING ALERTS - MAKES 300% WEEKLY RETURN HIGHLY RECOMMENDED
http://www.stocksmastermind.com

Dear Friends:

Our Exploding New Pick is Vivakor, Inc. VIVK http://www.vivakor.com/

VIVK is a trans-disciplinary biomedical/biotechnology company involved
in Discovering, Developing and Commercializing Solutions that
positively impact life. www.vivakor.com

VIVK plans to adapt a $300 Million potential technology upgrade to
produce and enhance MRI images which might improve MRI resolution
along with providing additional data such a blood flow velocity in
images tissues.

Market potential of about $15 Million just within 12 month
commercialization of the electro-optical devices released by VIVK.

VIVK have a fully integrated specialist team working on clinical trial
on Digital Photo screener, Opti-Ear and Anemia Monitor, having a
completion time of late 2009, positive results may drastically reduce
overall time and cost from previously used technology.

Experienced BOD Matthew Nicosia, Dr.Tannin Fuju and John Grayga have
strategically grown the revenue of VIVK from $20 Million to $120
Million. They approved a dividend to every share holders. Each share
holder will receive one HealthAmerica share for every share of Vivakor
Inc.

VIVK is currently in collaboration with University of IOWA, developing
a digital photo refractor that is intended to modernize child vision
screening. Approval has been granted from Western Institutional Review
Borad(20080731) to conduct human validation study.

VIVK has developed a series of nutraceutical formulations, including
VivaBlend, and plan to develop additional nutraceuticals, botanicals
and supplements. VIVK recently received 25000 units purchase order for
one of their products.

Critical advancement in the biological sample preservation are also
been evolved in VIVK. They have developed specialized Cryovials that
accommodate an improved method of cryopreservation of cells, blood and
other bio-materials.

VIVK have recently launched its sales products to Exploding Indian
Biotech market. Biopharma remains India’s biggest sector, accounting
for nearly 70% of the total revenues, expected to be worth US $5.7
Billion by 2012-2013. The future of the bio-supplier industry in India
looks very bright and so does of VIVK.

Check out Complete Presentation only at www.stockexploder.com

Please do your own due diligence on VIVK
All The Best

Exploder

www.stockexploder.com

 *Never invest in a stock mentioned by stockexploder.com unless you
can afford to lose your entire investment. For full disclaimer
http://www.stockexploder.com/disclaimer.html
tock exploder

Turn Your $1,000 Into Over 2 Million Dollars With Their Help  at
http://www.stocksmastermind.com

Turn Your $1,000 Into Over 2 Million Dollars With Their Help  at
http://www.stocksmastermind.com

Turn Your $1,000 Into Over 2 Million Dollars With Their Help  at
http://www.stocksmastermind.com

http://quote.barchart.com/texadv.asp?sym=EFUT

Yea,got off in it at $12,if it keeps runn'en monday I'll hold if not,
I'm out . Don't realy know how much of a long term future is in it.I
have mostly used it a few times for a cheap pump and dump. I don't
play that game to often but will every now and then.

Wednesday to Friday will be the most volatile market for October.RCH
might get a big hit downward. KUN, ATS, EFUT, XFML  will have their
big rally for this week. EJ, YGE, WX will be very volatile on their
prices. VM is slowly accumulating shares and will not have a big rally
this week. NCT is a good buy for good dividend .72 quarterly with
stable growth.It will have its biggest rally this week. As for the
investor and traders, be cautious in holding your stock for short
term. There is still a benefit for long term.

I'm spreading the word about this stock because I've exhausted myself
looking for a low-risk, legitimate Chinese investment & figure a lot
of others are as well.  Check out CHCG for yourself.  I feel I need to
be invested in China because the growth prospects in the U.S. will be
limited for 2008 due to the housing situation.  I own this stock, and
here's the reason:

- over $300 million in revenue expected in 2007 (had $148 million last
year)
- $0.50 per share expected in 2007
- signed an agreement with Best Buy in June
- plans to list its shares on the Nasdaq by the end of 2007
- trading at $5.35 per share; P/E ratio is 11x 2007 earnings

I couldn't believe it when I found it.  I bailed on ORS (also with
excellent growth potential) to buy this one.  I'm done for the year --
will just sit back & profit until I feel the stock is overvalued (in
the $30's, $40's?).

Check out the company's website for yourself: http://www.china3cgroup.com.
The reason (presumably) it's trading at such a low multiple is that
it's an OTC stock.  When it lists on the Nasdaq, look out.

I'm getting in STV first thing next week.  It's gonna be hot for sure.

Is it even possible to short this?  I doubt any shortable shares are
available.

Very true...! But looking at it's history, this puppy looks capable of
leaping up for no reason whatsoever, and I'd hate to be caught with my
pants down, so to speak, if EFUT jumps up another 10 bucks today. That
being said, there's lots of room for this to fall, so I'll consider
trading it again today. We'll just have to see.

should waited on your short position could go down way more this stock
run on news so if no news could go down real fAST

Good day to short this one. I sold some short around 32 and coverd
around 27.25. It'll be interesting to see how it trades tomorrow..

i havent shorted yet this stock will sqeeze out the shorts it still
has room to go up could reach 45  then there be availible short just
keep trying sometimes u can get lucky good luck especially if some one
margined and then there srewed and have to sell shorts